← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2012Last known activity
Dec 31, 2025
Timeline
2000s
- Jun 1, 2002
Sinocelltech Ltd.— Founded
Drugs by trial phase (47 distinct, 71 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (26 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Coronavirus Infections
- Esophageal Squamous Cell Carcinoma
- Head and Neck Neoplasms
- Hemophilia A
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Macular Degeneration
- Neoplasms
- Psoriasis
- Squamous Cell Carcinoma of Head and Neck
- Triple Negative Breast Neoplasms
Recent trials (50)
- NCT07297329Lead sponsorPhase 3Dec 31, 2025
- NCT07244510Lead sponsorPhase 2Nov 18, 2025
- NCT07077252Lead sponsorPhase 1/Phase 2Jul 28, 2025
- NCT07040072CollaboratorPhase 1Jun 30, 2025
- NCT07050641Lead sponsorPhase 1/Phase 2Jun 23, 2025
- NCT06841042Lead sponsorPhase 1/Phase 2Feb 28, 2025
- NCT06769984Lead sponsorPhase 1/Phase 2Feb 19, 2025
- NCT06801509Lead sponsorPhase 1/Phase 2Feb 15, 2025
- NCT06754605Lead sponsorPhase 1/Phase 2Feb 6, 2025
- NCT06774664Lead sponsorPhase 1/Phase 2Jan 31, 2025
- NCT06672536Lead sponsorPhase 1/Phase 2Nov 20, 2024
- NCT06600022Lead sponsorPhase 1/Phase 2Oct 10, 2024
- NCT06197009Lead sponsorPhase 2Jul 1, 2024
- NCT06318884Lead sponsorPhase 1Apr 30, 2024
- NCT06304818Lead sponsorPhase 1/Phase 2Apr 30, 2024
Details
- Founded
- Beijing, CN Jun 1, 2002
- Last known activity
- Dec 31, 2025